Antigoni Papanastasiou
AeroLeads people directory · profile

Antigoni Papanastasiou Email & Phone Number

Clinical Affairs Lead at Pharmathen
Location: Greece 12 work roles 3 schools
LinkedIn matched
✓ Verified July 2026 3 data sources Profile completeness 100%

Contact Signals

LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Clinical Affairs Lead
Location
Greece
Company size

Who is Antigoni Papanastasiou? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Antigoni Papanastasiou is listed as Clinical Affairs Lead at Pharmathen, a with 642 employees, based in Greece. AeroLeads shows a matched LinkedIn profile for Antigoni Papanastasiou.

Antigoni Papanastasiou previously worked as Clinical Affairs Lead, LAI division at Pharmathen and Clinical Affairs Expert (Manager) at Pharmathen. Antigoni Papanastasiou holds Msc, Molecular Medicine from Imperial College London.

Company email context

Email format at Pharmathen

This section adds company-level context without repeating Antigoni Papanastasiou's masked contact details.

Pharmathen

Review company-level records connected to Antigoni Papanastasiou before choosing the right outreach path.

Profile bio

About Antigoni Papanastasiou

Antigoni Papanastasiou is a Clinical Affairs Lead at Pharmathen. They possess expertise in horizon 2020, clinical trials, medical writing, in vitro in vivo correlation, clinical research and 22 more skills. They is proficient in English, French and Greek.

Listed skills include Horizon 2020, Clinical Trials, Medical Writing, In Vitro In Vivo Correlation, and 23 others.

Current workplace

Antigoni Papanastasiou's current company

Company context helps verify the profile and gives searchers a useful next step.

Pharmathen
Pharmathen
Clinical Affairs Lead
amstelveen, north holland, netherlands
Website
Employees
642
AeroLeads page
12 roles

Antigoni Papanastasiou work experience

A career timeline built from the work history available for this profile.

Clinical Affairs Lead, Lai Division

Athens, Attiki, Greece

Clinical Affairs Expert (Manager)

Attiki, Greece

Nov 2020 - Jan 2024

Clinical & Scientific Affairs Manager

Greece

Mar 2019 - Nov 2020

Scientific Affairs Senior Officer

Greece

Apr 2018 - Mar 2019

Scientific Affairs Officer

Scientific affairs department

Apr 2016 - Apr 2018

Medical And Clinical Associate

Greece

Product Evaluation and Design team

Dec 2013 - Apr 2016

Pharmacovigilance Officer

Feb 2013 - Nov 2013

Medical Reviewer/Biostatistician

Asklepeion Hospital
Dec 2012 - Feb 2013

Medical Writer

Freelance Medical Writing
Mar 2010 - 2013

Medical Information Expert/Emea Mi Team Member

EMEA MI team for newly launched Ustekinumab

Oct 2008 - Mar 2010

Researcher In Immunotherapy Of Pediatric Cancer

Publications1. Himoudi N, Yan MY, Papanastasiou A, Anderson J. MYCN as a target for immunotherapy. Cancer Immunol Immunother. 2008 Nov 15; 57(5): 693-700.2. Rees H, Williamson D, Papanastasiou A, Jina N, Nabarro S, Shipley J, Anderson J. The MET receptor tyrosine kinase contributes to invasive tumour growth in rhabdomyosarcomas. Growth Factors 2006; 24(3): 197-208.3. Nabarro S1, Himoudi N1, Papanastasiou A1 *, Gilmour K, Gibson S, Sebire N, Thrasher A, Blundell M, Hubank M, Canderan G, Anderson J.Coordinated oncogene transformation and inhibition of host immune responses by the PAX3-FKHR fusion oncoprotein. Journal of ExperimentalMedicine 2005; 203(10): 1399-1410.4. Godfrey A, Anderson J, Papanastasiou A, Takeuchi Y, Boshoff C. Inhibiting primary effusion lymphoma by lentiviral vectors encoding shorthairpin RNA. Blood 2005; 105 (6): 2510-8.5. A.Papanastasiou, Himoudi N, Yan MY, Anderson J. MYCN as a target for immunotherapy. Abstract Book of Keystone Conference: BasicAspects of tumour immunology II, 2005 March 19-24.

Oct 2002 - Apr 2007
Team & coworkers

Colleagues at Pharmathen

Other employees you can reach at pharmathen.gr. View company contacts for 642 employees →

3 education records

Antigoni Papanastasiou education

Msc, Molecular Medicine

Activities and Societies: 7-month research project in Gene targeting group/MRC led by Dr Andrew PorterBrough R, Papanastasiou AM, Porter.

FAQ

Frequently asked questions about Antigoni Papanastasiou

Quick answers generated from the profile data available on this page.

What company does Antigoni Papanastasiou work for?

Antigoni Papanastasiou works for Pharmathen.

What is Antigoni Papanastasiou's role at Pharmathen?

Antigoni Papanastasiou is listed as Clinical Affairs Lead at Pharmathen.

Where is Antigoni Papanastasiou based?

Antigoni Papanastasiou is based in Greece while working with Pharmathen.

What companies has Antigoni Papanastasiou worked for?

Antigoni Papanastasiou has worked for Pharmathen, Rafarm S.A, Asklepeion Hospital, Freelance Medical Writing, and Janssen-Cilag.

Who are Antigoni Papanastasiou's colleagues at Pharmathen?

Antigoni Papanastasiou's colleagues at Pharmathen include Christina Kiziridi, Katerina Minioti, Panagiotis Theofrastou, Sofia Kavvalou, and Anna Papadaki.

How can I contact Antigoni Papanastasiou?

You can use AeroLeads to view verified contact signals for Antigoni Papanastasiou at Pharmathen, including work email, phone, and LinkedIn data when available.

What schools did Antigoni Papanastasiou attend?

Antigoni Papanastasiou holds Msc, Molecular Medicine from Imperial College London.

What skills is Antigoni Papanastasiou known for?

Antigoni Papanastasiou is listed with skills including Horizon 2020, Clinical Trials, Medical Writing, In Vitro In Vivo Correlation, Clinical Research, Regulatory Affairs, Clinical Study Design, and Biostatistics.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.